Clinical trial
Pharmacokinetic Interactions Between Buprenorphine and Tipranavir/Ritonavir
NCT00486330 · Yale University, Other · Completed
Key facts
| NCT number | NCT00486330 |
|---|---|
| Title | Pharmacokinetic Interactions Between Buprenorphine and Tipranavir/Ritonavir |
| Official title | Pharmacokinetic Interactions Between Buprenorphine/Naloxone and Tipranavir/Ritonavir in HIV-Negative Subjects Chronically Receiving Buprenorphine/Naloxone |
| Acronym | BUTI |
| Lead sponsor | Yale University, Other |
| Collaborators | Boehringer Ingelheim Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | Buprenorphine, Tipranavir and ritonavir |
| Enrollment | 12 |
| Start date | May 1, 2006 |
| Primary completion | May 1, 2007 |
| Completion | May 1, 2007 |
| First posted | Jun 14, 2007 |
| Last update posted | Apr 20, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: